The Israeli Medicinal Mushroom Website

Medicinal Mushrooms, Chemotherapy, and the Hallmarks of Cancer Development:
Medicinal mushrooms contain polysaccharides known as beta-glucans and triterpenoid compounds that act as immunomodulatory molecules. In contrast to chemotherapeutic drugs, they do not directly target or kill cancer cells. Instead, they influence the regulation of key biological systems, primarily the immune system.
Beta-glucans bind to receptors on innate immune cells, such as Dectin-1 on macrophages and dendritic cells, leading to the activation of intracellular signaling pathways including NF-κB and MAPK. This activation enhances antigen presentation, increases the activity of natural killer (NK) cells and cytotoxic T cells, and shifts cytokine profiles toward a more effective immune response.
In the context of the cancer hallmarks, the discussed effects include regulation of chronic inflammation, which is a central component in the formation of a tumor-supportive microenvironment, indirect modulation of angiogenesis through changes in growth factor secretion, enhancement of apoptotic mechanisms, and improved immune surveillance that enables earlier recognition of abnormal cells.
A key aspect addressed is the potential integration with chemotherapy. Chemotherapy primarily acts by inducing DNA damage in rapidly dividing cells; however, its overall effectiveness is also influenced by immune system status and the body’s ability to manage inflammatory burden and cellular stress. In this context, medicinal mushrooms may function as supportive (adjuvant) agents by enhancing immune activity, promoting a more balanced inflammatory response, and potentially reducing chemotherapy-induced immunosuppression.
In addition, there is a research hypothesis suggesting that modulation of oxidative stress and cellular survival pathways by mushroom-derived compounds may influence how both cancer and healthy cells respond to chemotherapy. However, these mechanisms are complex and not yet fully defined, and the literature emphasizes the need for a precise understanding of the interactions between mushroom species, chemotherapeutic agents, and clinical context.
Therefore, medicinal mushrooms are presented as broad-spectrum biological modulators with potential supportive roles within oncological protocols, but not as a replacement for conventional treatment.